Dr Sekowska Leczenie Bolu
- Address
- Ul. Wolności 2 lok U5-80, 01-018 Warsaw, Poland
Nervous System Diseases
At Dr Sekowska Leczenie Bolu, researchers are focusing on migraine attacks, exploring new oral options for patients who cannot use traditional triptans. The goal is to assess how well a novel medication can relieve headache pain within a few hours of dosing.
- Acute migraine pain relief
- Placebo‑controlled efficacy assessment
- Alternative treatment pathways for triptan‑ineligible adults
The study involves a small team of investigators and aims to improve rapid symptom control, offering hope for better quality of life for migraine sufferers.
Skin and Connective Tissue Diseases
The site also conducts research on chronic spontaneous urticaria, testing a new compound to determine the most effective dose for reducing hives and itching. This work seeks to expand therapeutic options for patients with persistent skin symptoms.
- Dose‑ranging evaluation
- Symptom reduction and quality‑of‑life outcomes
- Safety and tolerability profiling
With two investigators leading the effort, the trial aims to identify a safe and reliable treatment that can bring lasting relief to individuals affected by chronic urticaria.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dr Sekowska Leczenie Bolu
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of EVO756 Potassium in Adults with Moderate to Severe Chronic Spontaneous Urticaria: A Randomized, Double-Blind, Placebo-Controlled Study | Evommune Inc. | Phase II | Not Recruiting | — | Jun 2026 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Desoximetasone | 1 | Unknown | 2024-01-29 | 2024-01-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.